- Home
- ERO vs VCYT Comparison
ERO vs VCYT Comparison
Compare ERO & VCYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ERO | VCYT |
|---|---|---|
| Founded | 2016 | 2006 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Medical Specialities |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 3.1B |
| IPO Year | 2021 | 2013 |
Fundamental Metrics
Financial Performance| Metric | ERO | VCYT |
|---|---|---|
| Price | $32.48 | $39.44 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 7 |
| Target Price | $36.50 | ★ $44.00 |
| AVG Volume (30 Days) | ★ 1.5M | 1.2M |
| Earning Date | 05-04-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 164.52 |
| EPS | N/A | ★ 0.66 |
| Revenue | N/A | N/A |
| Revenue This Year | $51.94 | $13.76 |
| Revenue Next Year | $2.43 | $12.35 |
| P/E Ratio | ★ $22.61 | $61.92 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $16.37 | $29.46 |
| 52 Week High | $40.83 | $60.91 |
Technical Indicators
Market Signals| Indicator | ERO | VCYT |
|---|---|---|
| Relative Strength Index (RSI) | 46.38 | 39.37 |
| Support Level | $33.52 | $40.80 |
| Resistance Level | $36.25 | $42.98 |
| Average True Range (ATR) | 1.73 | 1.80 |
| MACD | -0.66 | 0.13 |
| Stochastic Oscillator | 11.73 | 12.93 |
Price Performance
Historical ComparisonAbout ERO Ero Copper Corp.
Ero Copper Corp is a high-margin, high-growth copper producer with operations in Brazil. Its primary asset is its 99.6% ownership interest in Mineracao Caraiba S.A., held indirectly through its wholly-owned subsidiary. The company also owns a 97.6% ownership interest in NX Gold S.A. indirectly through its wholly-owned subsidiary. Its reporting segments include its three operating mines in Brazil, the Caraiba Operations, the Tucuma Operation, and the Xavantina Operations, and its corporate head office in Canada.
About VCYT Veracyte Inc.
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder).